Annette Vangsted

Annette Vangsted

UNVERIFIED PROFILE

Are you Annette Vangsted?   Register this Author

Register author
Annette Vangsted

Annette Vangsted

Publications by authors named "Annette Vangsted"

Are you Annette Vangsted?   Register this Author

42Publications

609Reads

Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study.

Eur J Haematol 2018 Oct 29. Epub 2018 Oct 29.

Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

View Article
October 2018

Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark.

Eur J Haematol 2018 Jul 4;101(1):21-27. Epub 2018 May 4.

Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

View Article
July 2018

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.

Br J Haematol 2016 09 16;174(6):991-3. Epub 2015 Nov 16.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article
September 2016

Synergy of two human endogenous retroviruses in multiple myeloma.

Leuk Res 2015 Oct 24;39(10):1125-8. Epub 2015 Jun 24.

Department of Biomedicin, Aarhus University, DK-8000 Aarhus C, Denmark. Electronic address:

View Article
October 2015

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

Endocr Relat Cancer 2015 Aug 22;22(4):545-59. Epub 2015 Jun 22.

Genomic Oncology AreaGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, SpainHematology DepartmentVirgen de las Nieves University Hospital, Granada, SpainGenomic Epidemiology GroupGerman Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of BiologyUniversity of Pisa, Pisa, ItalyDepartment of HematologyHospital Universitario Doce de Octubre, Madrid, SpainArea of Genomic MedicineGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, SpainSemmelweis UniversityBudapest, HungaryHaematology DepartmentUniversity Hospital of Salamanca and IBSAL, Salamanca, SpainMedical University of LodzLodz, PolandINSERM UMR 1052/CNRS 5286Université Claude Bernard Lyon I, Lyon, FranceMorales Meseguer General University HospitalMurcia, SpainHaematoloy ClinikHolly Cross Cancer Center, Kielce, PolandINSERMU900, Genetic Epidemiology of Cancers team, Institut Curie, Mines ParisTech, Paris, FranceLife and Health Sciences Research Institute (ICVS)School of Health Sciences, University of Minho, Braga, PortugalICVS/3B's - PT Government Associate LaboratoryBraga/Guimarães, PortugalMolecular Oncology Research CenterBarretos Cancer Hospital, Barretos, BrazilIDIBELL - Catalan Institute of OncologyUniversity of Barcelona, Barcelona 08907, SpainDepartment of HematologyCracow University Hospital, Cracow, PolandOrgan CenterHospital of Southern Jutland, DK-6200 Aabenraa, DenmarkFaculty of Health SciencesInstitute of Regional Health Research, University of Southern Denmark, DK-5000 Odense C, DenmarkUO HematologyDepartment of Internal and Experimental Medicine, University of Pisa, Pisa, ItalyClinic of Biochemistry and ImmunologyLaboratory Center, Hospital of Southern Jutland, Aabenraa, DenmarkDepartment of HaematologyRigshospitalet and Roskilde Hospital, Copenhagen University, Copenhagen, Denmark Genomic Oncology AreaGENYO, Cen

View Article
August 2015

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Nat Commun 2015 May 26;6:7213. Epub 2015 May 26.

1] Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, BMC B13, SE-221 84 Lund, Sweden [2] Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Akutgatan 8, SE-221 85 Lund, Sweden [3] Broad Institute, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article
May 2015

Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival.

Eur J Haematol 2015 Jan 16;94(1):60-6. Epub 2014 Jul 16.

Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.

View Article
January 2015

Genetic variants in the P2RX7 gene are associated with risk of multiple myeloma.

Eur J Haematol 2014 Aug 17;93(2):172-4. Epub 2014 May 17.

Department of Haematology, Roskilde Hospital, Copenhagen University, Roskilde, Denmark; Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Copenhagen, Denmark.

View Article
August 2014

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.

Cancer Epidemiol Biomarkers Prev 2014 Apr 12;23(4):670-4. Epub 2014 Feb 12.

Authors' Affiliations: Genomic Epidemiology Group, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Cracow University Hospital, Cracow; Medical University of Łodz; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Łodz; Rzeszow Regional Hospital, Rzeszow; Holycross Cancer Center, Kielce, Poland; Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; Morales Meseguer General University Hospital, Murcia; University Hospital of Salamanca, Salamanca; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government; Hematology Department, Virgen de las Nieves University Hospital, Granada; IDIBELL-Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; Semmelweis University, Budapest, Hungary; Institut National de la Santé et de la Recherche Medicale (INSERM) UMR 1052/CNRS 5286, Université Claude Bernard Lyon I, Lyon; Genetic Epidemiology of Cancer team, INSERM, U900, Institut Curie, Mines ParisTech, Paris, France; Department of Biology, University of Pisa, Pisa, Italy; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg; Organ Center, Hospital of Southern Jutland, Aabenraa; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense C; National Research Centre for the Working Environment, Copenhagen; Roskilde Hospital, Copenhagen University, Roskilde, Denmark; Life and Health Sciences Research Institute, University of Minho, Braga; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; UO Hematology, Department of Internal and Experimental Medicine, University of Pisa, Pisa, Italy; and Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

View Article
April 2014

Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma.

Int J Cancer 2012 Sep 31;131(5):E636-42. Epub 2012 Jan 31.

Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.

View Article
September 2012

A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma.

Br J Haematol 2012 Aug 28;158(4):515-8. Epub 2012 Apr 28.

Department of Haematology, Roskilde Hospital, Copenhagen University, Roskilde, Denmark.

View Article
August 2012

Genetic variations in multiple myeloma II: association with effect of treatment.

Eur J Haematol 2012 Feb 16;88(2):93-117. Epub 2011 Nov 16.

Department of Haematology, Roskilde Hospital, Copenhagen University, Roskilde, Denmark.

View Article
February 2012

Genetic variations in multiple myeloma I: effect on risk of multiple myeloma.

Eur J Haematol 2012 Jan 17;88(1):8-30. Epub 2011 Nov 17.

Department of Haematology, Roskilde Hospital, Copenhagen University, Roskilde, Denmark.

View Article
January 2012

Interferon-alpha in the treatment of multiple myeloma.

Curr Drug Targets 2011 Mar;12(3):437-46

Department of Hematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

View Article
March 2011

[Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma].

Ugeskr Laeger 2009 Jan;171(1-2):50-2

Klinisk Cellebiologi, Vejle Sygehus, DK-7100 Vejle.

View Article
January 2009